158 related articles for article (PubMed ID: 1727502)
1. Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat.
Ghosh D
J Virol; 1992 Jan; 66(1):586-90. PubMed ID: 1727502
[TBL] [Abstract][Full Text] [Related]
2. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.
Mitra D; Sikder SK; Laurence J
Virology; 1995 Dec; 214(2):512-21. PubMed ID: 8553553
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology.
Kino T; Kopp JB; Chrousos GP
J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):283-90. PubMed ID: 11282284
[TBL] [Abstract][Full Text] [Related]
4. Contacts between hormone receptor and DNA double helix within a glucocorticoid regulatory element of mouse mammary tumor virus.
Scheidereit C; Beato M
Proc Natl Acad Sci U S A; 1984 May; 81(10):3029-33. PubMed ID: 6328488
[TBL] [Abstract][Full Text] [Related]
5. Protein-protein interactions facilitate DNA binding by the glucocorticoid receptor DNA-binding domain.
Dahlman-Wright K; Siltala-Roos H; Carlstedt-Duke J; Gustafsson JA
J Biol Chem; 1990 Aug; 265(23):14030-5. PubMed ID: 1974254
[TBL] [Abstract][Full Text] [Related]
6. Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation.
Kolesnitchenko V; Snart RS
AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1977-80. PubMed ID: 1493048
[TBL] [Abstract][Full Text] [Related]
7. Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes.
Marcuzzi A; Weinberger J; Weinberger OK
J Virol; 1992 Jul; 66(7):4228-32. PubMed ID: 1602543
[TBL] [Abstract][Full Text] [Related]
8. A T-cell protein which recognizes a palindromic DNA sequence in the negative regulatory element of the HIV-1 long terminal repeat with homology to steroid/thyroid hormone receptor binding sites.
Orchard K; Perkins N; Chapman C; Harris J; Emery V; Goodwin G; Latchman D; Collins M
Biochem Soc Trans; 1990 Aug; 18(4):555-6. PubMed ID: 2276432
[No Abstract] [Full Text] [Related]
9. Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting.
Demarchi F; D'Agaro P; Falaschi A; Giacca M
J Virol; 1992 Apr; 66(4):2514-8. PubMed ID: 1548776
[TBL] [Abstract][Full Text] [Related]
10. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand.
Carr JK; Salminen MO; Koch C; Gotte D; Artenstein AW; Hegerich PA; St Louis D; Burke DS; McCutchan FE
J Virol; 1996 Sep; 70(9):5935-43. PubMed ID: 8709215
[TBL] [Abstract][Full Text] [Related]
11. New elements of glucocorticoid-receptor binding sites of hormone-regulated genes.
Seledtsov IA; Solovyev VV; Merkulova TI
Biochim Biophys Acta; 1991 Jul; 1089(3):367-76. PubMed ID: 1859840
[TBL] [Abstract][Full Text] [Related]
12. The mitochondrion as a primary site of action of glucocorticoids: the interaction of the glucocorticoid receptor with mitochondrial DNA sequences showing partial similarity to the nuclear glucocorticoid responsive elements.
Demonacos C; Djordjevic-Markovic R; Tsawdaroglou N; Sekeris CE
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):43-55. PubMed ID: 7577720
[TBL] [Abstract][Full Text] [Related]
13. Determinants of high-affinity DNA binding by the glucocorticoid receptor: evaluation of receptor domains outside the DNA-binding domain.
Dahlman-Wright K; Wright AP; Gustafsson JA
Biochemistry; 1992 Sep; 31(37):9040-4. PubMed ID: 1390690
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1.
Soudeyns H; Geleziunas R; Shyamala G; Hiscott J; Wainberg MA
Virology; 1993 Jun; 194(2):758-68. PubMed ID: 7684876
[TBL] [Abstract][Full Text] [Related]
15. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
16. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1.
Van Lint C; Ghysdael J; Paras P; Burny A; Verdin E
J Virol; 1994 Apr; 68(4):2632-48. PubMed ID: 8139041
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the human immunodeficiency virus type 1 long terminal repeat: interactions of thyroid hormone receptor with retinoid-X receptor, nuclear factor kappa B, Sp1, and Tat.
Desai-Yajnik V; Samuels HH
Trans Assoc Am Physicians; 1993; 106():13-32. PubMed ID: 8036737
[No Abstract] [Full Text] [Related]
18. Literature Abstracts.
S P; S A; H A; M JD; S A; Foods A; S A; M JD; S A; Pharmaceuticals B; Foods A
J Texture Stud; 1971 May; 2(2):249-256. PubMed ID: 28371981
[TBL] [Abstract][Full Text] [Related]
19. A nuclear matrix-specific factor that binds a specific segment of the negative regulatory element (NRE) of HIV-1 LTR and inhibits NF-kappa(B) activity.
Hoover T; Mikovits J; Court D; Liu YL; Kung HF; Raziuddin
Nucleic Acids Res; 1996 May; 24(10):1895-900. PubMed ID: 8657571
[TBL] [Abstract][Full Text] [Related]
20. Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains.
Schoenmakers E; Alen P; Verrijdt G; Peeters B; Verhoeven G; Rombauts W; Claessens F
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):515-21. PubMed ID: 10417312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
